BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND PIK3R1, P27986, 5295, ENSG00000145675, p85-ALPHA, GRB1
47 results:

  • 1. Genomic profile of Chinese patients with endometrial carcinoma.
    Li J; Li X; Quan C; Li X; Wan C; Wu X
    BMC Cancer; 2023 Sep; 23(1):888. PubMed ID: 37730563
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Proteogenomic insights suggest druggable pathways in endometrial carcinoma.
    Dou Y; Katsnelson L; Gritsenko MA; Hu Y; Reva B; Hong R; Wang YT; Kolodziejczak I; Lu RJ; Tsai CF; Bu W; Liu W; Guo X; An E; Arend RC; Bavarva J; Chen L; Chu RK; Czekański A; Davoli T; Demicco EG; DeLair D; Devereaux K; Dhanasekaran SM; Dottino P; Dover B; Fillmore TL; Foxall M; Hermann CE; Hiltke T; Hostetter G; Jędryka M; Jewell SD; Johnson I; Kahn AG; Ku AT; Kumar-Sinha C; Kurzawa P; Lazar AJ; Lazcano R; Lei JT; Li Y; Liao Y; Lih TM; Lin TT; Martignetti JA; Masand RP; Matkowski R; McKerrow W; Mesri M; Monroe ME; Moon J; Moore RJ; Nestor MD; Newton C; Omelchenko T; Omenn GS; Payne SH; Petyuk VA; Robles AI; Rodriguez H; Ruggles KV; Rykunov D; Savage SR; Schepmoes AA; Shi T; Shi Z; Tan J; Taylor M; Thiagarajan M; Wang JM; Weitz KK; Wen B; Williams CM; Wu Y; Wyczalkowski MA; Yi X; Zhang X; Zhao R; Mutch D; Chinnaiyan AM; Smith RD; Nesvizhskii AI; Wang P; Wiznerowicz M; Ding L; Mani DR; Zhang H; Anderson ML; Rodland KD; Zhang B; Liu T; Fenyö D;
    Cancer Cell; 2023 Sep; 41(9):1586-1605.e15. PubMed ID: 37567170
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A New Type of Endometrial cancer Models in Mice Revealing the Functional Roles of Genetic Drivers and Exploring their Susceptibilities.
    Chen J; Dai S; Zhao L; Peng Y; Sun C; Peng H; Zhong Q; Quan Y; Li Y; Chen X; Pan X; Zhong A; Wang M; Zhang M; Yang S; Lu Y; Lian Z; Liu Y; Zhou S; Li Z; Na F; Chen C
    Adv Sci (Weinh); 2023 Aug; 10(24):e2300383. PubMed ID: 37340596
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The cancer Genome Atlas-like Prognostic Subgroups.
    Irshaid L; Costigan DC; Dong F; Matulonis UA; Nucci MR; Kolin DL
    Mod Pathol; 2023 May; 36(5):100123. PubMed ID: 36857998
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
    Hall KC; Post MD; Alldredge J; Aisner DL; Berning A
    Int J Gynecol Pathol; 2023 Jul; 42(4):403-413. PubMed ID: 36305517
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Basigin is necessary for normal decidualization of human uterine stromal cells.
    Yang S; Bi J; Drnevich J; Li K; Nowak RA
    Hum Reprod; 2022 Nov; 37(12):2885-2898. PubMed ID: 36303457
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Systemic circulating microRNA landscape in Lynch syndrome.
    Sievänen T; Korhonen TM; Jokela T; Ahtiainen M; Lahtinen L; Kuopio T; Lepistö A; Sillanpää E; Mecklin JP; Seppälä TT; Laakkonen EK
    Int J Cancer; 2023 Mar; 152(5):932-944. PubMed ID: 36282188
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Towards less invasive molecular diagnostics for endometrial cancer: massively parallel sequencing of endometrial lavage specimens in women attending for an office hysteroscopy.
    Chao A; Wu KY; Lin CY; Lee YS; Huang HJ; Tang YH; Weng CH; Chao AS; Chang TC; Lai CH; Wu RC
    J Mol Med (Berl); 2022 Sep; 100(9):1331-1339. PubMed ID: 35953603
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. High incidence of PI3K pathway gene mutations in South Indian cervical cancers.
    Rose MM; Dhamodharan S; Revathidevi S; Chakkarappan SR; Jagadeesan MG; Subbiah S; Nakaoka H; Inoue I; Murugan AK; Munirajan AK
    Cancer Genet; 2022 Jun; 264-265():100-108. PubMed ID: 35568000
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genomic landscape of endometrial carcinomas of no specific molecular profile.
    Momeni-Boroujeni A; Nguyen B; Vanderbilt CM; Ladanyi M; Abu-Rustum NR; Aghajanian C; Ellenson LH; Weigelt B; Soslow RA
    Mod Pathol; 2022 Sep; 35(9):1269-1278. PubMed ID: 35365770
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Distinct Genomic Landscapes in Early-Onset and Late-Onset Endometrial cancer.
    Choi J; Holowatyj AN; Du M; Chen Z; Wen W; Schultz N; Lipworth L; Guo X
    JCO Precis Oncol; 2022 Feb; 6():e2100401. PubMed ID: 35108035
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 Positive Feedback Loop Induces Cell Cycle Arrest by Dual PI3K/mTOR Inhibitor PQR309 in Endometrial cancer Cell Lines.
    Hsin IL; Shen HP; Chang HY; Ko JL; Wang PH
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831139
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. miR-92a promotes cervical cancer cell proliferation, invasion, and migration by directly targeting pik3r1.
    Wang Y; Chen A; Zheng C; Zhao L
    J Clin Lab Anal; 2021 Aug; 35(8):e23893. PubMed ID: 34216514
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. PP2A and E3 ubiquitin ligase deficiencies: Seminal biological drivers in endometrial cancer.
    Gonzalez-Bosquet J; Bakkum-Gamez JN; Weaver AL; McGree ME; Dowdy SC; Famuyide AO; Kipp BR; Halling KC; Couch FJ; Podratz KC
    Gynecol Oncol; 2021 Jul; 162(1):182-189. PubMed ID: 33867147
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular differential analysis of uterine leiomyomas and leiomyosarcomas through weighted gene network and pathway tracing approaches.
    Sahly NN; Banaganapalli B; Sahly AN; Aligiraigri AH; Nasser KK; Shinawi T; Mohammed A; Alamri AS; Bondagji N; Elango R; Shaik NA
    Syst Biol Reprod Med; 2021 Jun; 67(3):209-220. PubMed ID: 33685300
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens.
    Akahane T; Kitazono I; Yanazume S; Kamio M; Togami S; Sakamoto I; Nohara S; Yokoyama S; Kobayashi H; Hiraki T; Suzuki S; Ueno S; Tanimoto A
    BMC Med Genomics; 2020 Jul; 13(1):101. PubMed ID: 32652986
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial cancer Subrogate Molecular Classification.
    Leskela S; Romero I; Rosa-Rosa JM; Caniego-Casas T; Cristobal E; Pérez-Mies B; Gutierrez-Pecharroman A; Santón A; Ojeda B; López-Reig R; Palacios-Berraquero ML; Andrada E; Montes S; Pastor F; Gomez MC; López-Guerrero JA; Poveda A; Palacios J
    Am J Surg Pathol; 2020 Jul; 44(7):982-990. PubMed ID: 32384322
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. An integrated molecular profile of endometrioid ovarian cancer.
    Pierson WE; Peters PN; Chang MT; Chen LM; Quigley DA; Ashworth A; Chapman JS
    Gynecol Oncol; 2020 Apr; 157(1):55-61. PubMed ID: 32139151
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway.
    Rubinstein MM; Hyman DM; Caird I; Won H; Soldan K; Seier K; Iasonos A; Tew WP; O'Cearbhaill RE; Grisham RN; Hensley ML; Troso-Sandoval T; Sabbatini P; Guillen J; Selcuklu SD; Zimel C; Torrisi J; Aghajanian C; Makker V
    Cancer; 2020 Mar; 126(6):1274-1282. PubMed ID: 31880826
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular profiling and molecular classification of endometrioid ovarian carcinomas.
    Cybulska P; Paula ADC; Tseng J; Leitao MM; Bashashati A; Huntsman DG; Nazeran TM; Aghajanian C; Abu-Rustum NR; DeLair DF; Shah SP; Weigelt B
    Gynecol Oncol; 2019 Sep; 154(3):516-523. PubMed ID: 31340883
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.